MicroRNA-504 modulates osteosarcoma cell chemoresistance to cisplatin by targeting p53
Sign Up to like & getrecommendations! Published in 2019 at "Oncology Letters"
DOI: 10.3892/ol.2018.9749
Abstract: Chemoresistance implicates the therapeutic value of cisplatin and remains a primary obstacle to its clinical use. MicroRNAs (miRs) negatively modulate the expression of their target genes and are associated with the occurrence and progression of… read more here.
Keywords: chemoresistance; microrna 504; cisplatin; p53 ... See more keywords